A cost-effectiveness analysis of escitalopram and sertraline in the treatment of major depressive disorder

被引：2
|
作者：
Armstrong, EP
Skrepnek, GH
Malone, DC
Erder, H
机构：
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[2] Forest Res Inst, Jersey City, NJ USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)63063-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany
    Kulp, W
    Hemels, M
    Greiner, W
    Graf, VDJ
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A210 - A210
  • [2] Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey
    Hemels, ME
    Karamustafyoglu, O
    Ozmen, E
    Dilsad, S
    Mene, S
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 392 - 392
  • [3] Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
    Mencacci, Claudio
    Di Sciascio, Guido
    Katz, Pablo
    Ripellino, Claudio
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 87 - 99
  • [4] Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder
    Armstrong, Edward P.
    Skrepnek, Grant H.
    Erder, M. Haim
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (02) : 251 - 258
  • [5] Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder
    Fantino, Bruno
    Moore, Nicholas
    Verdoux, Helene
    Auray, Jean-Paul
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 107 - 115
  • [6] Cost-effectiveness of Escitalopram vs. Venlafaxin XR in the treatment of major depressive disorder in Germany
    Kulp, W
    Greiner, W
    Schulenburg, JM
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 392 - 393
  • [7] Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria
    Hemels, MEH
    Kasper, S
    Walter, E
    Einarson, TR
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (06) : 869 - 878
  • [8] Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder
    Xie, Feng
    Despiegel, Nicolas
    Danchenko, Natalya
    Hansen, Karina
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 (01) : 59 - 69
  • [9] Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine in Major Depressive Disorder
    Despiegel, Nicolas
    Marteau, Florence
    Danchenko, Natalya
    Linne, Agneta Bjorck
    [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S12 - S12
  • [10] Cost-Effectiveness of Escitalopram in Major Depressive Disorder in the Dutch Health Care Setting
    Nuijten, Mark J. C.
    Brignone, Melanie
    Marteau, Florence
    den Boer, Johan A.
    Hoencamp, Erik
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (06) : 1364 - 1378
12345